相关实验视频

Updated: Jul 15, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

新的 (S) - - 异佐林-1,3,4-提亚醇混合物:合成,抗癌活性和诱导亡的作用

Mourad Fawzi¹, Abdoullah Bimoussa¹, Yassine Laamari¹

¹Laboratory of Molecular Chemistry, Unit of Organic Synthesis & Molecular Physicochemistry, Department of Chemistry, Faculty of Sciences Semlalia, PO Box 2390, Marrakech, 40001, Morocco.

Future medicinal chemistry

|September 29, 2023

概括

从 (S) - 烯衍生出的新型异佐林-1,3,4-提亚醇杂交物显示出显著的抗癌潜力. 化合物8b有效诱导乳腺癌细胞的亡和细胞循环停止,突出显示了一个有前途的新治疗途径.

科学领域:

药用化学医学化学
有机合成有机合成
癌症生物学癌症生物学

背景情况:

乳腺癌仍然是全球主要的死亡原因.
开发具有提高疗效和减少副作用的新型治疗剂至关重要.
(S) - 烯作为合成各种化学结构的有价值的起始材料.

研究的目的:

为了合成使用 (S) -verbenone的新型异zoline-1,3,4-thiadiazole杂交物.
评估这些新型杂交体对乳腺癌细胞系的细胞毒性和亡效应.
为了确定具有强大的抗癌活性的特定化合物,进行进一步的研究.

主要方法:

(S) - 被用作通过1,3-双极循环添加的混合合成的前体.
合成的化合物经历了严格的结构特征.
在激素敏感 (MCF-7) 和三阴性 (MDA-MB-231) 乳腺癌细胞上进行了合成混合体的体外查.

主要成果:

几种合成混合体在测试的细胞系中表现出显著的抗癌活性.
化合物8b对MCF-7和MDA-MB-231细胞表现出显著的细胞毒性.
发现化合物8b通过caspase-3/7通路诱导细胞亡,并导致细胞循环停止.

结论:

开发的 (S) - 烯异-1,3,4-亚二醇衍生物具有作为抗癌剂的显著潜力.
化合物8b强烈的亡活性使其成为乳腺癌治疗的有希望的候选者.
这项研究为基于 (S) - 烯衍生物的新型乳腺癌治疗开辟了新的研究方向.

关键词:

(S) - 烯 (S) - 烯是一种 1,3,4-提亚迪亚佐尔 (thiadiazole) 是一种可以灭症 (apoptosis) 是一种死亡的过程.乳腺癌乳腺癌乳腺癌在Caspase 3/7中使用.荷尔蒙敏感敏感的人混合化混合化混合化三次负的三重负.

更多相关视频

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones

Published on: January 21, 2020

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...